Description

EBOS Group Ltd (EBOS) is a supplier of healthcare products. The company markets sells, and distributes healthcare, medical and pharmaceutical products. It also markets and distributes animal care products and offers distribution, warehousing and logistics support to pharmaceutical manufacturers and medical device suppliers. The company offers products under various brands such as Symbion, Pro Pharma, Minfos, Master Pet, Vita Pet and Black Hawk. EBOS serves private and public hospitals, general practitioners, aged care facilities, specialist clinics, community centres, pharmacies, professionals, consumers, pet stores, veterinary clinics and manufacturers. It has a presence in Australia and New Zealand. EBOS is headquartered in Docklands, Victoria, Australia.

Founded in 1922 in Christchurch, New Zealand, EBOS Group has grown significantly over the years. It is publicly listed on both the New Zealand and Australian stock exchanges. The company generates substantial revenue, with a focus on sustainability and community impact.

EBOS Group is a leading Australasian company specializing in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products. It operates through two primary segments: Healthcare and Animal Care. The company provides a wide range of services, including healthcare logistics, pharmacy management software, medication management solutions, and community-based healthcare programs. It also supplies health and wellness products to hospitals, aged care facilities, clinics, and pharmacies.

In the Animal Care segment, EBOS Group offers pet nutrition, grooming products, veterinary supplies, and accessories for companion animals, production animals, and equine athletes. The company is committed to delivering high-quality products and services that positively impact the lives of millions of people and animals across Australasia.

Elizabeth Coutts:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Tracey Batten:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Mark Bloom:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Stuart McLauchlan:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Julie Tay:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Peter Williams:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Coline McConville:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Matt Muscio:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No

Subsribe/ Login to view details on company risk rating

 

5 Benchmark > 4 Excellent > 3  Good > 2 Caution > 1 Risk

 

 

 

NZX
NZEBOE0001S6
ASX
NZEBOE0001S6

 

Subscribe/ Login to view more details on Health Status 

 

Shareholders holding 5% +


For a comprehensive list, please contact InsidEntity.

Material Subsidiaries/Associates


For a comprehensive list, please contact InsidEntity.

 

Countries Operations/ Offices


 

Company Directors

Name
Nationality
Age
Role
Qualification
Name

Elizabeth

Non Executive
NationalityNew Zealand
RoleChair
QualificationONZM, BMS, FCA, CF Instit. D
Date Appointed: 01/07/2003
Duration:
23 years and 2 months
Independance: N
Name

Tracey

Non Executive
NationalityNew Zealand
RoleNED
QualificationMBBS, MHA, FRACMA, MBA, FAICD
Date Appointed: 01/07/2021
Duration:
5 years and 2 months
Independance: Y
Name

Mark

Non Executive
NationalityNew Zealand
RoleNED
QualificationBCom, BAcc, CA
Date Appointed: 16/09/2022
Duration:
3 years and 11 months
Independance: Y
Name

Stuart

Non Executive
NationalityNew Zealand
RoleNED
QualificationBCOM, FCA, CF. Inst.D
Date Appointed: 01/07/2019
Duration:
7 years and 2 months
Independance: Y
Name

Julie

Non Executive
NationalityNew Zealand
RoleNED
QualificationBA, MBA
Date Appointed: 01/05/2023
Duration:
3 years and 4 months
Independance: Y
Name

Peter

Non Executive
NationalityNew Zealand
RoleNED
QualificationNot Available
Date Appointed: 01/07/2013
Duration:
13 years and 2 months
Independance: N
Name

Coline Lucille

Non Executive
NationalityAustralia
62
RoleNED
QualificationMBA, LLB
Date Appointed: 01/02/2025
Duration:
1 year and 7 months
Independance: Y
Name

Matt

Non Executive
NationalityNew Zealand
RoleNED
QualificationPost-graduate business degree, Bachelor of Business in Marketing & International Business
Date Appointed: 01/01/2025
Duration:
1 year and 8 months
Independance: Y

 

Directors Tenure

Name
Duration
Name

Elizabeth Coutts

Duration23 years and 2 months
Name

Tracey Batten

Duration5 years and 2 months
Name

Mark Bloom

Duration3 years and 11 months
Name

Stuart McLauchlan

Duration7 years and 2 months
Name

Julie Tay

Duration3 years and 4 months
Name

Peter Williams

Duration13 years and 2 months
Name

Coline Lucille McConville

Duration1 year and 7 months
Name

Matt Muscio

Duration1 year and 8 months

 

Director Experience

Name
Experience
Name

Elizabeth

Experience Healthcare, Pharmaceutical, Government, Banking
Name

Tracey

Experience Healthcare, Insurance, Banking, Education, Government
Name

Mark

Experience Financial Services, Real Estate, Insurance, Other
Name

Stuart

Experience Technology, Other, Healthcare
Name

Julie

Experience Medical Equipment, Healthcare, Pharmaceutical
Name

Peter

Experience Healthcare
Name

Coline Lucille

Experience Television Services, Media and Advertising, Legal
Name

Matt

Experience Healthcare

 

Company Auditors

Name
Date Appointed
Years
Name

Deloitte

Date Appointed01/07/2003
Year23 years and 2 months

 

 

Company Committees

Name

Elizabeth Coutts

Mainboard, Audit, Remuneration BD, AU, RE
Name

Tracey Batten

Mainboard, Audit, Remuneration BD, RE
Name

Mark Bloom

Mainboard, Audit, Remuneration BD, AU
Name

Stuart McLauchlan

Mainboard, Audit, Remuneration BD, AU, RE
Name

Julie Tay

Mainboard, Audit, Remuneration BD
Name

Peter Williams

Mainboard, Audit, Remuneration BD
Name

Coline Lucille McConville

Mainboard, Audit, Remuneration BD
Name

Matt Muscio

Mainboard, Audit, Remuneration BD

 

Committee
Abbreviation
Supervisory Board
SB
Board
BD
Risk & Compliance
RC
Audit
AU
Remuneration
RE
Capital investment
CI
Industry Specific
IS
Nominations & Governance
NG
Health, Safety & Environment
HS
Social & Ethics
SE
Technology
TE
Executive
EX
Other
OT